-
Fmoc-3-(2-Naphthyl)-L-alanine 112883-43-9
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Immunology | Peptide synthesis | Amino acid series | Fmoc-3-(2-Naphthyl)-L-alanine | CAS:112883-43-9 | C28H23NO4
-
Fmoc-Trp(Boc)-OH 143824-78-6
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Immunology | Peptide synthesis | Fmoc-Trp(Boc)-OH | CAS:143824-78-6 | C31H30N2O6
-
Fmoc-L-Leucine 35661-60-0
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Immunology | Peptide synthesis | Amino acid series | Fmoc-L-Leucine | CAS:35661-60-0 | C21H23NO4
-
Fmoc-D-leucine 114360-54-2
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Immunology | Peptide synthesis | Amino acid series | Fmoc-D-leucine | CAS:114360-54-2 | C21H23NO4
-
![N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3](https://www.yisunbio.com/uploads/281.jpg)
N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Immunology | Peptide synthesis | N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine | CAS:1202003-49-3 | C27H34N2O6
-
![O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7](https://www.yisunbio.com/uploads/29-300x115.jpg)
O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Immunology | Peptide synthesis | O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine | CAS:1013883-02-7 | C31H34N2O7
-
Hippuric acid 495-69-2
Professional manufacturing and supply biopharmaceutical | Raw Materials | Pharmaceutical Intermediates Reagents | Immunology | Peptide synthesis | Hippuric acid | CAS:495-69-2 | C9H9NO3
-
Valsartan 137862-53-4
Professional manufacturing and supply biopharmaceutical | Chemical Reagents | Chemical Raw materials | Industrial pharmaceutical intermediate | Cardiovascular | Hypertension treatment | Valsartan Intermediates | Valsartan | CAS:137862-53-4 | C24H29N5O3
-
L-Valine methyl ester hydrochloride 6306-52-1
Professional manufacturing and supply biopharmaceutical | Chemical Reagents | Chemical Raw materials | Industrial pharmaceutical intermediate | Cardiovascular | Valsartan Intermediates | L-Valine methyl ester hydrochloride | CAS:6306-52-1 | C6H13NO2.HCl
-
![N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3](https://www.yisunbio.com/uploads/34.jpg)
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3
Professional manufacturing and supply biopharmaceutical | Chemical Reagents | Chemical Raw materials | Industrial pharmaceutical intermediate | Cardiovascular | Hypertension treatment | Valsartan Intermediates | N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride | CAS:482577-59-3 | C20H22N2O2.HCl
-
Valsartan methyl ester 137863-17-3
Professional manufacturing and supply biopharmaceutical | Chemical Reagents | Chemical Raw materials | Industrial pharmaceutical intermediate | Cardiovascular | Hypertension treatment | Valsartan Intermediates | N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine methyl ester | CAS:137863-17-3 | C25H31N5O3
-
(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethanol 126534-31-4
Professional manufacturing and supply biopharmaceutical | Pharmaceutical Intermediates Reagents | Infectious diseases | Dermatologic | Luliconazole Intermediates | (S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethano | CAS:126534-31-4 | C8H7Cl3O